Related Experiment Video
Updated: Apr 7, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Early phase cancer clinical trials: design, ethics and future directions
Nicholas Coupe1, Avinash Gupta2, Simon R Lord3
1Clinical Research Fellow in Medical Oncology.
Abstract:
The main role of early phase clinical trials in cancer is to determine the dose to take forward for future clinical study. However, study design is changing in order to account for the change in focus of drug development toward molecularly targeted agents.
Insights
Early phase cancer trials determine optimal drug dosage. Study designs are evolving to focus on molecularly targeted agents in cancer drug development.
Area of Science:
- Oncology
- Clinical Pharmacology
- Drug Development
Background:
- Early phase clinical trials are crucial for establishing the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) for novel cancer therapeutics.
- Traditional dose-escalation designs are well-established but may not be optimal for all new drug classes.
Purpose of the Study:
- To describe the evolving role of early phase clinical trials in cancer research.
- To highlight the impact of molecularly targeted agents on trial design.
Main Methods:
- Review of current early phase clinical trial designs.
- Analysis of how drug development trends influence study methodologies.
- Discussion of adaptive and novel trial designs.
Main Results:
- The primary objective of dose determination remains central to early phase trials.
- A shift towards incorporating molecular profiling and targeted therapies necessitates design modifications.
- Newer designs aim for greater efficiency and earlier assessment of efficacy signals.
Conclusions:
- Early phase cancer trial designs are adapting to the era of precision medicine.
- Future trials will increasingly integrate molecularly targeted agents and potentially novel designs to optimize drug development pathways.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Preclinical Development: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis